셀루메드 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 티디랜드마크조합1호, was filed 11 Feb 2026.
Who traded when
BuySaleSince the insiders bought
- -36.5%Entry ₩1,590 · Close 30 Oct 2026 ₩1,009
- -64.3%Entry ₩2,205 · Close at T+365 ₩788
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 0KRXDART:20260323000848
- 2,686,005 sharesKRXDART:20260319001248
- ●Executives0DART
- ●Executives0DART
- 1,056,754 sharesKRXDART:20260213002636
- ShareKRXDART:20260211000903Canonical exit: 12 May 2026 (T+90)
- 28,192,370 sharesKRXDART:20260128000429Canonical exit: 21 Apr 2026 (T+90)
- 28,192,370 sharesShareKRXDART:20260128000440Canonical exit: 28 Apr 2026 (T+90)
- 42,000 sharesKRXDART:20250930000607Canonical exit: 11 Dec 2025 (T+90)
- 3,698,441 sharesKRXDART:20250826000505
- 1,260,152 sharesKRXDART:20250825000370Canonical exit: 16 Nov 2025 (T+90)
- ●Executives0DART
- 5,359,057 sharesKRXDART:20241105000081Canonical exit: 30 Jan 2025 (T+90)
- 0KRXDART:20241105000093
- 30,000 sharesKRXDART:20241008000556Canonical exit: 28 Oct 2024 (T+90)
- 0KRXDART:20240805000129
- 480,000 sharesKRXDART:20240801000079
- 5,359,057 sharesKRXDART:20240611000403Canonical exit: 4 Jun 2024 (T+90)
- 2,327,108 sharesKRXDART:20240411003884
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 5,359,057 sharesKRXDART:20231006000490Canonical exit: 24 Dec 2023 (T+90)
- ShareKRXDART:20231006000393Canonical exit: 26 Dec 2023 (T+90)
- 5,359,057 sharesKRXDART:20230710000482Canonical exit: 25 Sept 2023 (T+90)
25 of 38 declarations
About 셀루메드
인스코비, filed as 대량보유자, is behind 19 of the 38 filings at 셀루메드, a South Korean health care company valued at KRW 84.0 billion and 42.2% held by insiders. It has 13 purchases and 3 sales there. 티디랜드마크조합1호 adds 6 purchases across 6 filings, and 상상인저축은행 1 purchase and 1 sale. The company 셀루메드 itself appears in 9 filings. The record gathers 20 purchases, 5 sales and 13 filings of another kind, for trades dated May 3, 2023 to March 16, 2026. No amount is reported. From August 18 to September 12, 2025, 2 filers bought. Filings span February 17, 2021 to March 23, 2026, with a maximum of 10 in 2024, 8 in both 2023 and 2026, and 4 in each of 2021, 2022 and 2025. The last twelve months count 8 filings, 3 purchases and 2 sales. Thirteen purchases have a stored 90-day result: median minus 21%, 15% positive, a record of the past.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
